AUPN Fall Chairs Session III:
Navigating Neurotherapeutic Horizons: Managing the Practical Aspects of the Novel Alzheimer’s Therapeutics
Tuesday, September 17, 2024 | 7am – 8:30am ET
In conjunction with the ANA Annual Meeting

Coming May 7th!

Course Description

In this symposium we will explore the challenges and opportunities of establishing a clinical program to offer Lecanemab for patients with mild cognitive symptoms due to Alzheimer’s disease.

Learning Objectives

• Appropriate indications for lecanemab
• Common and serious adverse reactions and how to appropriately monitor
• Working with insurance companies

Moderator & Speakers